We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

71 hedge funds and large institutions have $373M invested in Korro Bio in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 19

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

4% more funds holding

Funds holding: 68 → 71 (+3)

0.09% more ownership

Funds ownership: 1.07% → 1.15% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $382M → $373M (-$9.3M)

Holders
71
Holders Change
+3
Holders Change %
+4.41%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
27
Reduced
19
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$27.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.19M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$7.5M
4
RI
RTW Investments
New York
+$6.44M
5
PA
Perceptive Advisors
New York
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
-$1.78M
2
HighTower Advisors
HighTower Advisors
Illinois
-$1.61M
3
BCM
Burrage Capital Management
Massachusetts
-$1.5M
4
Morgan Stanley
Morgan Stanley
New York
-$1.48M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
51
MetLife Investment Management
New Jersey
$250K – – –
OC
52
Oppenheimer & Co
New York
$242K +$45.1K +42 +20%
PCM
53
Pinz Capital Management
New York
$231K +$258K +240 New
RMCM
54
Reynders McVeigh Capital Management
Massachusetts
$228K +$255K +238 New
Morgan Stanley
55
Morgan Stanley
New York
$225K -$1.48M -1,380 -86%
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
$218K +$244K +227 New
Cerity Partners
57
Cerity Partners
New York
$192K – – –
Bank of America
58
Bank of America
North Carolina
$177K -$85.9K -80 -30%
MLICM
59
Metropolitan Life Insurance Company (MetLife)
New York
$173K – – –
GFPC
60
Global Financial Private Client
Florida
$59.6K – – –
Legal & General Group
61
Legal & General Group
United Kingdom
$58K -$35.4K -33 -35%
AIP
62
Ameritas Investment Partners
Nebraska
$41K -$7.51K -7 -14%
SO
63
STRS Ohio
Ohio
$28K – – –
Citigroup
64
Citigroup
New York
$23K -$56.9K -53 -69%
BG
65
Bollard Group
Massachusetts
$21K – – –
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$17K – – –
UBS Group
67
UBS Group
Switzerland
$15K -$191K -178 -92%
PFS
68
Prospera Financial Services
Texas
$15K +$17.2K +16 New
CHA
69
Carmichael Hill & Associates
Maryland
$5K – – –
ASN
70
Advisory Services Network
Georgia
$2K +$2.15K +2 New
KFS
71
Kelly Financial Services
Massachusetts
$1.34K – – –
Allianz Asset Management
72
Allianz Asset Management
Germany
– -$1.78M -1,532 Closed
SG Americas Securities
73
SG Americas Securities
New York
– -$355K -306 Closed
Goldman Sachs
74
Goldman Sachs
New York
– -$234K -201 Closed
VOYA Investment Management
75
VOYA Investment Management
Georgia
– -$228K -196 Closed
1 2
3
4

KRRO Hedge Fund Activity: Q3 2020 in Review

71 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2020, worth a combined $373M — down 2.4% from $382M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KRRO positions and 8 closed out — a net gain of 3 holders — while 27 added to existing stakes and 19 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $27.1M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $1.78M sold.

  • 71 institutional investors held Korro Bio (KRRO) as of Q3 2020, up from 68 in Q2 2020.
  • Funds reported $373M of Korro Bio stock for Q3 2020, down 2.4% quarter-over-quarter.
  • 11 funds opened new Korro Bio positions in Q3 2020 and 8 closed out, a net change of +3 holders.
  • The largest Korro Bio buyer in Q3 2020 was Wasatch Advisors, an estimated $27.1M added.
  • The largest Korro Bio seller in Q3 2020 was Allianz Asset Management, an estimated $1.78M sold.

Based on aggregated 13F filings for Q3 2020.